Page last updated: 2024-11-13
pacific blue succinimidyl ester
Description
Pacific Blue succinimidyl ester: a fluorescent dye [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
pacific blue succinimidyl ester : An N-hydroxysuccinimide ester derived from 6,8-difluoro-7-hydroxycoumarin-3-carboxylic acid (pacific blue). A fluorescent dye of excitation wavelength 403 nm and emission wavelength 455 nm. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
ID Source | ID |
PubMed CID | 56927770 |
CHEBI ID | 63240 |
SCHEMBL ID | 13494176 |
MeSH ID | M0498471 |
Synonyms (26)
Synonym |
pacific blue n-hydroxysuccinimidyl ester |
6,8-difluoro-7-hydroxy-2-oxo-2h-chromene-3-carboxylic acid succinimidyl ester |
pacific blue succinimidyl ester |
6,8-difluoro-7-hydroxy-2-oxo-2h-chromene-3-carboxylic acid n-hydroxysuccinimidyl ester |
CHEBI:63240 |
1-{[(6,8-difluoro-7-hydroxy-2-oxo-2h-chromen-3-yl)carbonyl]oxy}pyrrolidine-2,5-dione |
SCHEMBL13494176 |
3-carboxy-6,8-difluoro-7-hydroxycoumarin succinimidyl ester |
mfcd28155193 |
6,8-difluoro-7-hydroxy-2-oxo-2h-1-benzopyran-3-carboxylic acid 2,5-dioxo-1-pyrrolidinyl ester |
215868-33-0 |
(2,5-dioxopyrrolidin-1-yl) 6,8-difluoro-7-hydroxy-2-oxochromene-3-carboxylate |
J-014158 |
Q27132506 |
ocean blue, se |
3-carboxy-6,8-difluoro-7-hydroxycoumaryl succinimidyl ester |
AT21712 |
2,5-dioxopyrrolidin-1-yl 6,8-difluoro-7-hydroxy-2-oxo-2h-chromene-3-carboxylate |
pacific blue nhs ester |
BP-27948 |
pb succinimidyl ester |
HY-133532 |
CS-0120928 |
DTXSID701304383 |
pb nhs ester |
AKOS040757365 |
Roles (1)
Role | Description |
fluorochrome | A fluorescent dye used to stain biological specimens. |
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Drug Classes (3)
Class | Description |
hydroxycoumarin | Any coumarin carrying at least one hydroxy substituent. |
organofluorine compound | An organofluorine compound is a compound containing at least one carbon-fluorine bond. |
N-hydroxysuccinimide ester | An ester of N-hydroxysuccinimide. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (7)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 17.69
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 17.69 (24.57) | Research Supply Index | 2.08 (2.92) | Research Growth Index | 4.59 (4.65) | Search Engine Demand Index | 10.37 (26.88) | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |